EAM Investors’s Cardlytics CDLX Stock Holding History

EAM Investors’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16,714	Closed	-$2.76M	–	260
2023 Q3	$2.76M	Buy	+16,714	New	+$2.17M	0.53%	46
2021 Q1	–	Sell	-1,548	Closed	-$2.21M	–	350
2020 Q4	$2.21M	Buy	+1,548	New	+$1.65M	0.36%	91
2020 Q1	–	Sell	-6,112	Closed	-$3.84M	–	228
2019 Q4	$3.84M	Sell	6,112 -3,594	-37%	-$1.76M	0.85%	14
2019 Q3	$3.25M	Buy	9,706 +5,302	+120%	+$1.7M	0.86%	11
2019 Q2	$1.14M	Buy	+4,404	New	+$882K	0.28%	165
2018 Q3	–	Sell	-4,139	Closed	-$901K	–	310
2018 Q2	$901K	Buy	+4,139	New	+$766K	0.14%	216

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return

EAM Investors's CDLX Position: Q4 2023 in Review

EAM Investors sold out of Cardlytics (CDLX) in Q4 2023, closing a stake of 16,714 shares — an estimated $2.76M sold.

EAM Investors first reported a position in CDLX in Q2 2018 and held it in 6 quarters. The position peaked at $3.84M in Q4 2019. 124 funds tracked by Wall St. Rank hold CDLX as of Q4 2023.

EAM Investors reported no remaining Cardlytics position as of Q4 2023 after selling out during the quarter.
EAM Investors sold 16,714 Cardlytics shares in Q4 2023, an estimated $2.76M.
EAM Investors first reported a position in Cardlytics in Q2 2018 and held it in 6 quarters.
EAM Investors's Cardlytics position peaked at $3.84M in Q4 2019.
124 funds tracked by Wall St. Rank held Cardlytics as of Q4 2023.

Based on EAM Investors's 13F filing for Q4 2023, filed 14 Feb 2024.